Skip to content

Control treatment schedule

DRUG3 trials

Sponsors

Mario Negri Institute for Pharmacological Research, Second Affiliated Hospital of Nanchang University

Conditions

COVID 19Cerebral HemorrhageCovid19Intraventricular Hemorrhage

Related Papers